Shelton biotech Intensity Therapeutics paused its Phase 3 cancer trial after running low on cash. The company needs $30M to finish testing INT230-6, an injectable drug that attacks tumors directly.

COVID-era financial assistance for ObamaCare health plans are all but guaranteed to lapse at the end of the year.

There’s no mistaking the joy in Michael Waterbury’s voice as he recalls his introduction to the world of health insurance. It ...

A medical office building in Bristol that opened in May recently sold for nearly $20 million.

Hartford HealthCare's bid to acquire Manchester Memorial and Rockville General hospitals would also give it full ownership of two ambulance services, potentially controlling one-third of Connecticut's ...

The funding will clear the way for redevelopment projects that could add housing, commercial space and jobs, officials said.

The West Hartford Town Council on Wednesday unanimously approved an application to demolish a nearly 2,400-square-foot, ...

What a difference a year makes. Last fall, climate research, green energy and sustainable choices seemed to be on a roll.

Community Foundation for Greater New Haven is on track to surpass last year's $33.3M fundraising total in CEO Karen ...

The Mashantucket Pequot Tribal Nation plans to reopen the Two Trees Inn in Ledyard in spring 2026 and has selected Waterford ...

Yale New Haven Health has purchased the Stratford property of Nelson Ambulance Service as part of acquiring the North ...

The former chair of the Public Utilities Regulatory Authority was found to have mishandled a request for public records ...